{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:32:27Z","timestamp":1791297147933,"version":"4.1.0"},"reference-count":50,"publisher":"Impact Journals, LLC","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2014,9,15]]},"DOI":"10.18632\/oncotarget.2273","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T23:38:30Z","timestamp":1442360310000},"page":"7549-7562","source":"Crossref","is-referenced-by-count":45,"title":["Elevated TAK1 augments tumor growth and metastatic capacities of ovarian cancer cells through activation of NF-\u03baB signaling"],"prefix":"10.18632","volume":"5","author":[{"given":"Patty C.H.","family":"Cai","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynaecology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, P.R.China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, P.R.China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent W.S.","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, P.R.China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermit W.M.","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, P.R.China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris J.","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, P.R.China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H.Y.","family":"Leung","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, P.R.China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen K.L.","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, P.R.China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy W.P.","family":"Yam","sequence":"additional","affiliation":[{"name":"Department of Pathology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, P.R.China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwok-Ming","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, P.R.China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hextan Y.S.","family":"Ngan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, P.R.China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, P.R.China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2014,7,27]]},"reference":[{"issue":"2","key":"1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global Cancer Statistics","volume":"61","author":"Forman","year":"2011","journal-title":"Ca-a Cancer Journal for Clinicians"},{"issue":"8","key":"2","first-page":"S45","article-title":"Ovarian cancer: prevention, detection, and treatment of the disease and its recurrence. Molecular mechanisms and personalized medicine meeting report","volume":"22","author":"Edwards","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"3","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.7314\/APJCP.2012.13.4.1333","article-title":"Resveratrol Exerts Differential Effects in Vitro and in Vivo against Ovarian Cancer Cells.","volume":"13","author":"Bishayee","year":"2012","journal-title":"Asian Pacific Journal of Cancer Prevention"},{"issue":"9","key":"4","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.2217\/fon.12.111","article-title":"The future of glioma treatment: stem cells, nanotechnology and personalized medicine","volume":"8","author":"Murad","year":"2012","journal-title":"Future Oncol"},{"issue":"5","key":"5","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1053\/j.seminoncol.2012.08.007","article-title":"New therapeutic challenges in advanced bladder cancer","volume":"39","author":"Petrylak","year":"2012","journal-title":"Semin Oncol"},{"issue":"4","key":"6","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ucl.2012.07.005","article-title":"Moving toward personalized medicine in castration-resistant prostate cancer","volume":"39","author":"Pomerantz","year":"2012","journal-title":"Urol Clin North Am"},{"issue":"45","key":"7","first-page":"2327","article-title":"[The change of pathology in the era of personalized medicine using the example of discordant KRAS mutational status in metastasized colorectal carcinoma]","volume":"137","author":"Bosse","year":"2012","journal-title":"Dtsch Med Wochenschr"},{"issue":"8","key":"8","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1158\/1078-0432.CCR-10-3265","article-title":"The biphasic role of NF-kappaB in progression and chemoresistance of ovarian cancer","volume":"17","author":"Liu","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"5","key":"9","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s10552-011-9745-4","article-title":"Genomics of the NF-kappa B signaling pathway: hypothesized role in ovarian cancer","volume":"22","author":"Goode","year":"2011","journal-title":"Cancer Causes & Control"},{"issue":"10","key":"10","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1158\/0008-5472.CAN-09-3912","article-title":"Activation of NF-kappaB signaling by inhibitor of NF-kappaB kinase beta increases aggressiveness of ovarian cancer","volume":"70","author":"Annunziata","year":"2010","journal-title":"Cancer Res"},{"issue":"22","key":"11","doi-asserted-by":"crossref","first-page":"23477","DOI":"10.1074\/jbc.M313709200","article-title":"Inhibition of NFkappaB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models","volume":"279","author":"Murata","year":"2004","journal-title":"J Biol Chem"},{"issue":"68","key":"12","first-page":"7","article-title":"Advances in the treatment of ovarian cancer: a potential role of antiinflammatory phytochemicals","volume":"13","author":"Butler-Manuel","year":"2012","journal-title":"Discov Med"},{"key":"13","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.mce.2009.04.012","article-title":"TAK1 activation for cytokine synthesis and proliferation of endometriotic cells","volume":"307","author":"Terakawa","year":"2009","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"14","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1073\/pnas.0909781107","article-title":"Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis","volume":"107","author":"Seki","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"21","key":"15","doi-asserted-by":"crossref","first-page":"8417","DOI":"10.1158\/0008-5472.CAN-10-1227","article-title":"Ablation of TAK1 upregulates reactive oxygen species and selectively kills tumor cells","volume":"70","author":"Ninomiya-Tsuji","year":"2010","journal-title":"Cancer Res"},{"issue":"15","key":"16","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1093\/jnci\/djr243","article-title":"Modulation of pancreatic cancer chemoresistance by inhibition of TAK1","volume":"103","author":"Chiao","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"17","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.cell.2011.12.033","article-title":"TAK1 inhibition promotes apoptosis in KRAS-dependent colon cancers","volume":"148","author":"Settleman","year":"2012","journal-title":"Cell"},{"issue":"10","key":"18","doi-asserted-by":"crossref","first-page":"7359","DOI":"10.1074\/jbc.275.10.7359","article-title":"TAK1 mitogen-activated protein kinase kinase kinase is activated by autophosphorylation within its activation loop","volume":"275","author":"Ninomiya-Tsuji","year":"2000","journal-title":"J Biol Chem"},{"issue":"36","key":"19","doi-asserted-by":"crossref","first-page":"24497","DOI":"10.1074\/jbc.M802825200","article-title":"Phosphorylation of Thr-178 and Thr-184 in the TAK1 T-loop is required for interleukin (IL)-1-mediated optimal NFkappaB and AP-1 activation as well as IL-6 gene expression","volume":"283","author":"Yang","year":"2008","journal-title":"J Biol Chem"},{"issue":"8","key":"20","doi-asserted-by":"crossref","first-page":"7359","DOI":"10.1074\/jbc.M407537200","article-title":"Critical roles of threonine 187 phosphorylation in cellular stress-induced rapid and transient activation of transforming growth factor-beta-activated kinase 1 (TAK1) in a signaling complex containing TAK1-binding protein TAB1 and TAB2","volume":"280","author":"Sakurai","year":"2005","journal-title":"J Biol Chem"},{"issue":"12","key":"21","doi-asserted-by":"crossref","first-page":"11395","DOI":"10.1074\/jbc.M411189200","article-title":"Prostaglandin E2 enhances osteoclastic differentiation of precursor cells through protein kinase A-dependent phosphorylation of TAK1","volume":"280","author":"Takahashi","year":"2005","journal-title":"J Biol Chem"},{"issue":"3","key":"22","doi-asserted-by":"crossref","first-page":"G475","DOI":"10.1152\/ajpgi.00071.2011","article-title":"Specific effects of BCL10 Serine mutations on phosphorylations in canonical and noncanonical pathways of NF-kappa B activation following carrageenan","volume":"301","author":"Tobacman","year":"2011","journal-title":"American Journal of Physiology-Gastrointestinal and Liver Physiology"},{"key":"23","first-page":"395329","article-title":"H11\/HspB8 and Its Herpes Simplex Virus Type 2 Homologue ICP10PK Share Functions That Regulate Cell Life\/Death Decisions and Human Disease","volume":"2012","author":"Lee","year":"2012","journal-title":"Autoimmune Dis"},{"issue":"3","key":"24","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","article-title":"Ovarian cancer development and metastasis","volume":"177","author":"Lengyel","year":"2010","journal-title":"Am J Pathol"},{"issue":"4","key":"25","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0002-9440(10)63370-6","article-title":"Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion","volume":"165","author":"Hendrix","year":"2004","journal-title":"Am J Pathol"},{"issue":"8","key":"26","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1158\/1541-7786.MCR-10-0196","article-title":"TAK1-TAB2 signaling contributes to bone destruction by breast carcinoma cells","volume":"9","author":"Bakin","year":"2011","journal-title":"Mol Cancer Res"},{"issue":"9","key":"27","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/sj.onc.1210768","article-title":"TAK1 is required for TGF-beta 1-mediated regulation of matrix metalloproteinase-9 and metastasis","volume":"27","author":"Bakin","year":"2008","journal-title":"Oncogene"},{"issue":"14","key":"28","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1128\/MCB.01139-10","article-title":"A cytosolic ATM\/NEMO\/RIP1 complex recruits TAK1 to mediate the NF-kappaB and p38 mitogen-activated protein kinase (MAPK)\/MAPK-activated protein 2 responses to DNA damage","volume":"31","author":"Kelliher","year":"2011","journal-title":"Mol Cell Biol"},{"issue":"4","key":"29","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.molcel.2004.08.008","article-title":"TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains","volume":"15","author":"Chen","year":"2004","journal-title":"Mol Cell"},{"issue":"2","key":"30","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ncb1823","article-title":"Interaction between TAK1-TAB1-TAB2 and RCAN1-calcineurin defines a signalling nodal control point","volume":"11","author":"Molkentin","year":"2009","journal-title":"Nat Cell Biol"},{"issue":"6","key":"31","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.humpath.2008.10.019","article-title":"Cleaved caspase-3 and nuclear factor-kappaB p65 are prognostic factors in metastatic serous ovarian carcinoma","volume":"40","author":"Davidson","year":"2009","journal-title":"Hum Pathol"},{"issue":"13","key":"32","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1002\/cncr.25190","article-title":"Nuclear factor kappaB transcription factors are coexpressed and convey a poor outcome in ovarian cancer","volume":"116","author":"Kohn","year":"2010","journal-title":"Cancer"},{"issue":"16 Suppl 2","key":"33","first-page":"S1","article-title":"NF-kappaB as a target for pancreatic cancer therapy","author":"Melisi","year":"2012","journal-title":"Expert Opin Ther Targets"},{"issue":"7","key":"34","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4161\/cbt.11.7.14903","article-title":"Targeting NFkB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2","volume":"11","author":"Beckman","year":"2011","journal-title":"Cancer Biol Ther"},{"issue":"24","key":"35","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.4161\/cc.5.24.3558","article-title":"TGF-beta activated kinase-1: new insights into the diverse roles of TAK1 in development and immunity","volume":"5","author":"Mlodzik","year":"2006","journal-title":"Cell Cycle"},{"issue":"1","key":"36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2217\/14796694.5.1.1","article-title":"TGF-beta uses the E3-ligase TRAF6 to turn on the kinase TAK1 to kill prostate cancer cells","volume":"5","author":"Landstrom","year":"2009","journal-title":"Future Oncol"},{"issue":"11","key":"37","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1158\/0008-5472.CAN-11-2724","article-title":"Suppression of Tak1 promotes prostate tumorigenesis","volume":"72","author":"Cramer","year":"2012","journal-title":"Cancer Res"},{"issue":"4","key":"38","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/hep.23878","article-title":"The MAP3K TAK1: a chock block to liver cancer formation","volume":"52","author":"Willenbring","year":"2010","journal-title":"Hepatology"},{"issue":"12","key":"39","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/ni.2157","article-title":"The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammation","volume":"12","author":"Venuprasad","year":"2011","journal-title":"Nat Immunol"},{"key":"40","article-title":"TGF-beta and NF-kappaB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers","author":"Van Waes","year":"2012","journal-title":"Oncogene"},{"issue":"5","key":"41","doi-asserted-by":"crossref","first-page":"373","DOI":"10.18632\/oncotarget.170","article-title":"Mouse models of hepatocarcinogenesis: what can we learn for the prevention of human hepatocellular carcinoma?","volume":"1","author":"Luedde","year":"2010","journal-title":"Oncotarget"},{"issue":"2","key":"42","first-page":"53","article-title":"Comparison of tumor grade and stage with nuclear factor kappa b and p38 mitogene activated protein kinase expressions in renal cell cancer","volume":"84","author":"Somay","year":"2012","journal-title":"Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica \/ Associazione ricerche in urologia"},{"issue":"10","key":"43","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.tips.2012.06.007","article-title":"Targeting of TAK1 in inflammatory disorders and cancer","volume":"33","author":"Sakurai","year":"2012","journal-title":"Trends Pharmacol Sci"},{"key":"44","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/sj.bjc.6690149","article-title":"Increased expression of the RIalpha subunit of the cAMP-dependent protein kinase A is associated with advanced stage ovarian cancer","volume":"79","author":"Johnston","year":"1999","journal-title":"Br J Cancer"},{"issue":"3","key":"45","first-page":"73","article-title":"Activation of the PKC pathway stimulates ovarian cancer cell proliferation, migration, and expression of MMP7 and MMP10","volume":"89","author":"Curry","year":"2013","journal-title":"Biology of reproduction"},{"issue":"23","key":"46","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1007\/s00018-011-0757-8","article-title":"Cyclic AMP: a selective modulator of NF-kappaB action","volume":"68","author":"Haegeman","year":"2011","journal-title":"Cellular and molecular life sciences : CMLS"},{"issue":"36","key":"47","doi-asserted-by":"crossref","first-page":"28097","DOI":"10.1074\/jbc.M110.116566","article-title":"A-kinase-interacting protein 1 (AKIP1) acts as a molecular determinant of PKA in NF-kappaB signaling","volume":"285","author":"Okamoto","year":"2010","journal-title":"J Biol Chem"},{"issue":"5","key":"48","doi-asserted-by":"crossref","first-page":"e37076","DOI":"10.1371\/journal.pone.0037076","article-title":"Increased expression of PITX2 transcription factor contributes to ovarian cancer progression","volume":"7","author":"Ngan","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"49","doi-asserted-by":"crossref","first-page":"e52578","DOI":"10.1371\/journal.pone.0052578","article-title":"Targeting GRB7\/ERK\/FOXM1 signaling pathway impairs aggressiveness of ovarian cancer cells","volume":"7","author":"Ngan","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"50","doi-asserted-by":"crossref","first-page":"e23790","DOI":"10.1371\/journal.pone.0023790","article-title":"Aberrant activation of ERK\/FOXM1 signaling cascade triggers the cell migration\/invasion in ovarian cancer cells","volume":"6","author":"Ngan","year":"2011","journal-title":"PLoS One"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.2273","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T10:31:31Z","timestamp":1599561091000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.2273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,27]]},"references-count":50,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2014,9,15]]}},"alternative-id":["2273","25277189"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.2273","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,27]]}}}